Weak association between arterial hypertension and overactive bladder baseline symptoms and treatment responses

dc.contributor.authorMichel, Martin Christian
dc.contributor.authorHeemann, Uwe W.
dc.contributor.authorde la Rosette, Jean Jmch M.C.H.
dc.contributor.departmentBiomedical Engineering Program
dc.contributor.facultyMaroun Semaan Faculty of Engineering and Architecture (MSFEA)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:26:00Z
dc.date.available2025-01-24T11:26:00Z
dc.date.issued2022
dc.description.abstractWhile animal studies have suggested an association between the presence of hypertension and the presence and/or severity of overactive bladder syndrome (OAB) symptoms, little clinical data is available. We have conducted a pre-specified secondary analysis of a non-interventional study involving 4450 OAB patients being treated with solifenacin to explore the existence of an association between OAB and hypertension using three parallel and overlapping definitions of hypertension to enhance robustness of analysis. Regardless of definition, patients with hypertension were older and had greater OAB symptom severity in univariate analyses. In multiple regression models including age as explanatory covariate, most relationships held up but effect sizes of concomitant hypertension on OAB severity were small (odds ratios <1.35 in all cases) and were deemed to be unlikely of clinical relevance. % Changes in symptom severity were somewhat smaller in univariate analysis, but effect sizes were small. We conclude that OAB and arterial hypertension are associated but effect sizes are too small to justify adaptation of clinical practice for OAB patients with concomitant hypertension. Copyright © 2022 Michel, Heemann and de la Rosette.
dc.identifier.doihttps://doi.org/10.3389/fphar.2022.1081074
dc.identifier.eid2-s2.0-85145070462
dc.identifier.urihttp://hdl.handle.net/10938/26471
dc.language.isoen
dc.publisherFrontiers Media S.A.
dc.relation.ispartofFrontiers in Pharmacology
dc.sourceScopus
dc.subjectArterial hypertension
dc.subjectNon-interventional study
dc.subjectOveractive bladder syndrome
dc.subjectPathophysiology
dc.subjectSolifenacin
dc.subjectTreatment
dc.subjectAngiotensin receptor antagonist
dc.subjectBeta adrenergic receptor blocking agent
dc.subjectCalcium channel blocking agent
dc.subjectDipeptidyl carboxypeptidase inhibitor
dc.subjectDiuretic agent
dc.subjectAdult
dc.subjectAged
dc.subjectArticle
dc.subjectControlled study
dc.subjectCoronary artery disease
dc.subjectCytokine release
dc.subjectDiastolic blood pressure
dc.subjectDisease severity
dc.subjectFemale
dc.subjectHuman
dc.subjectHypertension
dc.subjectMajor clinical study
dc.subjectMale
dc.subjectMicturition
dc.subjectMultiple regression
dc.subjectNocturia
dc.subjectOvary cancer
dc.subjectOveractive bladder
dc.subjectPostvoid residual urine volume
dc.subjectRisk factor
dc.subjectTreatment response
dc.subjectUrge incontinence
dc.titleWeak association between arterial hypertension and overactive bladder baseline symptoms and treatment responses
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-1225.pdf
Size:
611.83 KB
Format:
Adobe Portable Document Format